SlideShare a Scribd company logo
1 of 21
French Healthcare Payers and Medical Experts In depth Interviews
We understand your business ,[object Object]
What opportunities lie ahead with more treatments administered by a combination of drugs and devices?
How are contract research organisations and contract manufacturers reshaping the industry?The pharmaceuticals and healthcare sector  is going through continuous transformation. Ask Medipharm@Network to take advice from  French Healthcare Payers or Medical Experts
We understand your business ,[object Object]
Our Network includes amongst others
Payers
KOL
Healthcare Service Providers
Patients Organizations and Networks.
Healthcare Practitioners and Scientists across Biotechnology and General     Pharmaceutical PracticesAccess our Network of Experts Ask Medipharm@Network to take advice from  French Healthcare Payers or Medical Experts
We understand your business As your strategic market intelligence and advisory partner, we can help: ,[object Object]
Identify the market size and future growth of new indications for a given drug
Research R&D and marketing best practices from competitors and identify how this can be replicatedUnderstand, Compete and Grow in French Markets Ask Medipharm@Network to take advice from  French Healthcare Payers or Medical Experts
We understand your business And also we can help: ,[object Object]
Monitor regulatory issues affecting pharmaceutical and medical equipment companies and anticipate new opportunity areas
Deliver specific training to negative  Experts or KOL that help you take your intelligence operations to the next levelUnderstand, Compete and Grow in French Markets Ask Medipharm@Network to take advice from  French Healthcare Payers or Medical Experts
We provide valuable information about your markets and industry Flexible, Responsive and Reliable ,[object Object]
Medipharm@Network has a proven record of swiftly mobilizing its Rapid Response Research resources and delivering results within days, no matter what intelligence challenges our clients face.
Such mission-critical assignments typically make use of our professional databases, experts network and primary research capabilities in France.Ask Medipharm@Network to take advice from  French Healthcare Payers or Medical Experts
We provide valuable information about your markets and industry In brief, we can help you rapidly: ,[object Object]

More Related Content

What's hot

Drug value optimization excerpts
Drug value optimization   excerptsDrug value optimization   excerpts
Drug value optimization excerptsJean-Michel Peny
 
Best in-class Key Account Managers
Best in-class Key Account ManagersBest in-class Key Account Managers
Best in-class Key Account ManagersJean-Michel Peny
 
Best in class pharma market research vf web
Best in class pharma market research vf   webBest in class pharma market research vf   web
Best in class pharma market research vf webJean-Michel Peny
 
Creativity and Performance
Creativity and PerformanceCreativity and Performance
Creativity and PerformanceJean-Michel Peny
 
Roadmap to reimbursement and access
Roadmap to reimbursement and accessRoadmap to reimbursement and access
Roadmap to reimbursement and accessRhonda Greenapple
 
VERSA PULS MEDIA, S.R.L.
VERSA PULS MEDIA, S.R.L.VERSA PULS MEDIA, S.R.L.
VERSA PULS MEDIA, S.R.L.Petr Němec
 
Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)
Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)
Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)Asgar Hussain Inamdar
 
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...Len Starnes
 
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...Eularis
 
How does the licensing process differ for in-licensing and out-licensing comp...
How does the licensing process differ for in-licensing and out-licensing comp...How does the licensing process differ for in-licensing and out-licensing comp...
How does the licensing process differ for in-licensing and out-licensing comp...daisyrmuzzio
 
Playing to win in the life science tools market
Playing to win in the life science tools marketPlaying to win in the life science tools market
Playing to win in the life science tools marketBill Kelly
 
Best in-class Medical Reps
Best in-class Medical RepsBest in-class Medical Reps
Best in-class Medical RepsJean-Michel Peny
 
2011June PharmaceuticalMarketEurope ValuableCollection
2011June PharmaceuticalMarketEurope ValuableCollection2011June PharmaceuticalMarketEurope ValuableCollection
2011June PharmaceuticalMarketEurope ValuableCollectionAleksandar Ruzicic
 
Background note for ad hoc group on med
Background note for ad hoc group on medBackground note for ad hoc group on med
Background note for ad hoc group on medJames Andrews
 
Guidelines for prescription drug marketing in India
Guidelines for prescription drug marketing in IndiaGuidelines for prescription drug marketing in India
Guidelines for prescription drug marketing in IndiaDr Neelesh Bhandari
 
Upcoming Issue 31st April 2015 special issue exclusively on "Technology in He...
Upcoming Issue 31st April 2015 special issue exclusively on "Technology in He...Upcoming Issue 31st April 2015 special issue exclusively on "Technology in He...
Upcoming Issue 31st April 2015 special issue exclusively on "Technology in He...yahyasultan
 
Business Plan on a Bio-Tech product
Business Plan on a Bio-Tech productBusiness Plan on a Bio-Tech product
Business Plan on a Bio-Tech productTarkeshwar Singh
 

What's hot (20)

Healthcare Brand Management Market Access Concepts - Healthcare Marketing Str...
Healthcare Brand Management Market Access Concepts - Healthcare Marketing Str...Healthcare Brand Management Market Access Concepts - Healthcare Marketing Str...
Healthcare Brand Management Market Access Concepts - Healthcare Marketing Str...
 
Drug value optimization excerpts
Drug value optimization   excerptsDrug value optimization   excerpts
Drug value optimization excerpts
 
Best in-class Key Account Managers
Best in-class Key Account ManagersBest in-class Key Account Managers
Best in-class Key Account Managers
 
Best in class pharma market research vf web
Best in class pharma market research vf   webBest in class pharma market research vf   web
Best in class pharma market research vf web
 
Creativity and Performance
Creativity and PerformanceCreativity and Performance
Creativity and Performance
 
Otc opportunity
Otc opportunityOtc opportunity
Otc opportunity
 
Roadmap to reimbursement and access
Roadmap to reimbursement and accessRoadmap to reimbursement and access
Roadmap to reimbursement and access
 
Puls Media Network
Puls Media NetworkPuls Media Network
Puls Media Network
 
VERSA PULS MEDIA, S.R.L.
VERSA PULS MEDIA, S.R.L.VERSA PULS MEDIA, S.R.L.
VERSA PULS MEDIA, S.R.L.
 
Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)
Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)
Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)
 
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...
 
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
 
How does the licensing process differ for in-licensing and out-licensing comp...
How does the licensing process differ for in-licensing and out-licensing comp...How does the licensing process differ for in-licensing and out-licensing comp...
How does the licensing process differ for in-licensing and out-licensing comp...
 
Playing to win in the life science tools market
Playing to win in the life science tools marketPlaying to win in the life science tools market
Playing to win in the life science tools market
 
Best in-class Medical Reps
Best in-class Medical RepsBest in-class Medical Reps
Best in-class Medical Reps
 
2011June PharmaceuticalMarketEurope ValuableCollection
2011June PharmaceuticalMarketEurope ValuableCollection2011June PharmaceuticalMarketEurope ValuableCollection
2011June PharmaceuticalMarketEurope ValuableCollection
 
Background note for ad hoc group on med
Background note for ad hoc group on medBackground note for ad hoc group on med
Background note for ad hoc group on med
 
Guidelines for prescription drug marketing in India
Guidelines for prescription drug marketing in IndiaGuidelines for prescription drug marketing in India
Guidelines for prescription drug marketing in India
 
Upcoming Issue 31st April 2015 special issue exclusively on "Technology in He...
Upcoming Issue 31st April 2015 special issue exclusively on "Technology in He...Upcoming Issue 31st April 2015 special issue exclusively on "Technology in He...
Upcoming Issue 31st April 2015 special issue exclusively on "Technology in He...
 
Business Plan on a Bio-Tech product
Business Plan on a Bio-Tech productBusiness Plan on a Bio-Tech product
Business Plan on a Bio-Tech product
 

Viewers also liked

Hec Santé H&C N° 332 Sept Oct 2009 Article Grippe A
Hec Santé   H&C N° 332   Sept Oct 2009   Article Grippe AHec Santé   H&C N° 332   Sept Oct 2009   Article Grippe A
Hec Santé H&C N° 332 Sept Oct 2009 Article Grippe AMedipharmaNetwork
 
Provider Payer Integration (Himss11 192)
Provider Payer Integration (Himss11   192)Provider Payer Integration (Himss11   192)
Provider Payer Integration (Himss11 192)Wayne Pan
 
Healthcare Payer and Provider Webinar
Healthcare Payer and Provider WebinarHealthcare Payer and Provider Webinar
Healthcare Payer and Provider WebinarInformatica Cloud
 
Healthcare payer medical informatics and analytics
Healthcare payer medical informatics and analyticsHealthcare payer medical informatics and analytics
Healthcare payer medical informatics and analyticsFrank Wang
 
Hype vs. Reality: The AI Explainer
Hype vs. Reality: The AI ExplainerHype vs. Reality: The AI Explainer
Hype vs. Reality: The AI ExplainerLuminary Labs
 
Study: The Future of VR, AR and Self-Driving Cars
Study: The Future of VR, AR and Self-Driving CarsStudy: The Future of VR, AR and Self-Driving Cars
Study: The Future of VR, AR and Self-Driving CarsLinkedIn
 

Viewers also liked (7)

Hec Santé H&C N° 332 Sept Oct 2009 Article Grippe A
Hec Santé   H&C N° 332   Sept Oct 2009   Article Grippe AHec Santé   H&C N° 332   Sept Oct 2009   Article Grippe A
Hec Santé H&C N° 332 Sept Oct 2009 Article Grippe A
 
Provider Payer Integration (Himss11 192)
Provider Payer Integration (Himss11   192)Provider Payer Integration (Himss11   192)
Provider Payer Integration (Himss11 192)
 
US Medical Research And Dvt
US Medical Research And DvtUS Medical Research And Dvt
US Medical Research And Dvt
 
Healthcare Payer and Provider Webinar
Healthcare Payer and Provider WebinarHealthcare Payer and Provider Webinar
Healthcare Payer and Provider Webinar
 
Healthcare payer medical informatics and analytics
Healthcare payer medical informatics and analyticsHealthcare payer medical informatics and analytics
Healthcare payer medical informatics and analytics
 
Hype vs. Reality: The AI Explainer
Hype vs. Reality: The AI ExplainerHype vs. Reality: The AI Explainer
Hype vs. Reality: The AI Explainer
 
Study: The Future of VR, AR and Self-Driving Cars
Study: The Future of VR, AR and Self-Driving CarsStudy: The Future of VR, AR and Self-Driving Cars
Study: The Future of VR, AR and Self-Driving Cars
 

Similar to Us Medipharm@Network Presentation

mHealth Israel_UK Healthcare, Retail and DTC Market Overview
mHealth Israel_UK Healthcare, Retail and DTC Market OverviewmHealth Israel_UK Healthcare, Retail and DTC Market Overview
mHealth Israel_UK Healthcare, Retail and DTC Market OverviewLevi Shapiro
 
Canada Dermatology prescription Market
Canada Dermatology prescription MarketCanada Dermatology prescription Market
Canada Dermatology prescription MarketInsights10
 
Direct INFO for Healthcare sector in Russia
Direct INFO for Healthcare sector in RussiaDirect INFO for Healthcare sector in Russia
Direct INFO for Healthcare sector in Russiadirectinforu
 
Key AI Trends Propelling a Sea Change in Post-pandemic care
Key AI Trends Propelling a Sea Change in Post-pandemic careKey AI Trends Propelling a Sea Change in Post-pandemic care
Key AI Trends Propelling a Sea Change in Post-pandemic careInsights10
 
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015 Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015 WilheminaRossi174
 
ttopstart - Business development and strategic planning
ttopstart - Business development and strategic planningttopstart - Business development and strategic planning
ttopstart - Business development and strategic planningttopstart B.V.
 
Neil Grubert's introduction to the EPP Life Sciences Executive Briefing
Neil Grubert's introduction to the EPP Life Sciences Executive BriefingNeil Grubert's introduction to the EPP Life Sciences Executive Briefing
Neil Grubert's introduction to the EPP Life Sciences Executive BriefingEuropean Pricing Platform
 
Medical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 BerlinMedical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 BerlinGaurav Mishra
 
ALP_AMD without recording file
ALP_AMD without recording fileALP_AMD without recording file
ALP_AMD without recording fileHONGRAK KIM
 
What is the real value of digital pharma marketing?
What is the real value of digital pharma marketing?What is the real value of digital pharma marketing?
What is the real value of digital pharma marketing?Jean-Michel Peny
 
Vertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaignVertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaignGary Leikin
 

Similar to Us Medipharm@Network Presentation (20)

mHealth Israel_UK Healthcare, Retail and DTC Market Overview
mHealth Israel_UK Healthcare, Retail and DTC Market OverviewmHealth Israel_UK Healthcare, Retail and DTC Market Overview
mHealth Israel_UK Healthcare, Retail and DTC Market Overview
 
Canada Dermatology prescription Market
Canada Dermatology prescription MarketCanada Dermatology prescription Market
Canada Dermatology prescription Market
 
Direct INFO for Healthcare sector in Russia
Direct INFO for Healthcare sector in RussiaDirect INFO for Healthcare sector in Russia
Direct INFO for Healthcare sector in Russia
 
Pharma Chronicle
Pharma ChroniclePharma Chronicle
Pharma Chronicle
 
Patient centric strategy
Patient centric strategyPatient centric strategy
Patient centric strategy
 
Key AI Trends Propelling a Sea Change in Post-pandemic care
Key AI Trends Propelling a Sea Change in Post-pandemic careKey AI Trends Propelling a Sea Change in Post-pandemic care
Key AI Trends Propelling a Sea Change in Post-pandemic care
 
Acute Lung Injury - Pipeline Insight, 2018
Acute Lung Injury - Pipeline Insight, 2018Acute Lung Injury - Pipeline Insight, 2018
Acute Lung Injury - Pipeline Insight, 2018
 
Process Management Services
Process Management ServicesProcess Management Services
Process Management Services
 
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015 Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
Smart Pharma Consulting 1, rue Houdart de Lamotte – 75015
 
ttopstart - Business development and strategic planning
ttopstart - Business development and strategic planningttopstart - Business development and strategic planning
ttopstart - Business development and strategic planning
 
Neil Grubert's introduction to the EPP Life Sciences Executive Briefing
Neil Grubert's introduction to the EPP Life Sciences Executive BriefingNeil Grubert's introduction to the EPP Life Sciences Executive Briefing
Neil Grubert's introduction to the EPP Life Sciences Executive Briefing
 
Medical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 BerlinMedical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 Berlin
 
Arthroscopy device market
Arthroscopy device marketArthroscopy device market
Arthroscopy device market
 
ALP_AMD without recording file
ALP_AMD without recording fileALP_AMD without recording file
ALP_AMD without recording file
 
Market Intelligence Services
Market Intelligence ServicesMarket Intelligence Services
Market Intelligence Services
 
LS e-book
LS e-bookLS e-book
LS e-book
 
Med Byte
Med ByteMed Byte
Med Byte
 
Vulvar Cancer - Pipeline Insight, 2018
Vulvar Cancer - Pipeline Insight, 2018Vulvar Cancer - Pipeline Insight, 2018
Vulvar Cancer - Pipeline Insight, 2018
 
What is the real value of digital pharma marketing?
What is the real value of digital pharma marketing?What is the real value of digital pharma marketing?
What is the real value of digital pharma marketing?
 
Vertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaignVertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaign
 

Us Medipharm@Network Presentation

  • 1. French Healthcare Payers and Medical Experts In depth Interviews
  • 2.
  • 3. What opportunities lie ahead with more treatments administered by a combination of drugs and devices?
  • 4. How are contract research organisations and contract manufacturers reshaping the industry?The pharmaceuticals and healthcare sector is going through continuous transformation. Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 5.
  • 6. Our Network includes amongst others
  • 8. KOL
  • 11. Healthcare Practitioners and Scientists across Biotechnology and General Pharmaceutical PracticesAccess our Network of Experts Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 12.
  • 13. Identify the market size and future growth of new indications for a given drug
  • 14. Research R&D and marketing best practices from competitors and identify how this can be replicatedUnderstand, Compete and Grow in French Markets Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 15.
  • 16. Monitor regulatory issues affecting pharmaceutical and medical equipment companies and anticipate new opportunity areas
  • 17. Deliver specific training to negative Experts or KOL that help you take your intelligence operations to the next levelUnderstand, Compete and Grow in French Markets Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 18.
  • 19. Medipharm@Network has a proven record of swiftly mobilizing its Rapid Response Research resources and delivering results within days, no matter what intelligence challenges our clients face.
  • 20. Such mission-critical assignments typically make use of our professional databases, experts network and primary research capabilities in France.Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 21.
  • 22. Screen market players
  • 23. Profile companies, markets and products
  • 24. List out sales leads
  • 25. Analyze your competitive landscapeAsk Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 26.
  • 34. ENT
  • 56. VisceralSurgeryAsk Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 57.
  • 59. Market Sizing, Market Segmentation & Market Forecasts
  • 63. M&A Screening & Evaluation
  • 66. Business Expansion AnalysisAsk Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 67.
  • 68. Customized research approach based on individual needs
  • 69. Europe-class secondary research capability and primary research capability(1)(1) Together with Consumed Research Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 70. Strategic analysis Medipharm@Network provides analytical insight and advisory Objective: Enabling you to compete more effectively and Grow into new opportunities Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 71.
  • 73. new marketsMedipharm@Network will tap into its global network of over 150 domain experts to tailor a team that best suits your strategic analysis needs. Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 74. Case study examples HYPERTENSION (1) Hypertension-related regulatory research for a consulting company Key benefits Gained insight on how Health Insurance Physicians working in National Health Service regulate approval of full reimbursement (100% as ALD, i.e. Long Duration Disease), with focus on Hypertension and differences in service accounting of cardiologists. Need A renowned consulting company needed opinions and insights of Health Insurance Physicians on specific procedures. The timeframe was just 7 days to gather their views on the topic. Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 75. Case study examples HYPERTENSION (2) Approach: In-depth interviews with Associations and Cardiologists to gain insight into approval regulations and service accounting. Methods: Primary research, i.e. expert and payers interviews Results: Regulatory and accounting information on the Health Insurance Physicians in France delivered to the client 3 days after the request. Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 76. Case study examples Medical Equipment (1) Defined optimal market segmentation in France for a medical equipment company based in US Key benefits: Enabled market share increase by quantifying the size of greatest opportunity customer and channel segments Need: A manufacturer of medical equipment wanted to size the demand for testing products in France. Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 77. Case study examples Medical Equipment (2) Approach: Multiple-level demand sizing and segmentation approach, including validation of overall market size, segmentation of customer types, and definition of channel shares for each customer type. Methods: Secondary & primary research and analysis Results : Confirmed that the demand opportunity for testing products was promising. Identified channels and customer groups that would drive the greatest sales volumes within the shortest timeframe. Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 78. Case study examples Rheumatology (1) Identified rheumatoid arthritis patient profiles and attitudes in nine French Region versus Paris Key benefits: The client gained a better understanding of rheumatoid arthritis patients Need: A European pharmaceutical company needed to know how to better target rheumatoid arthritis patients in France. Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 79. Case study examples Rheumatology (2) Approach: Conducted in-depth interviews with rheumatoid arthritis physicians across 9 different Regions plus Paris. Methods: Primary research and analysis Results : Analyzed patients expectations and unmet needs. Ranked needs and established patient profiles. Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 80. Case study examples Elastic Bandages (1) Researched elastic bandages costs of major hospitals outside French “Assistance Publique “ Key benefits: The client gained a better understanding of the elastic bandages costs at major hospitals outside French Assistance Publique. Need: A global supplier wanted to benchmark its elastic bandages prices with other players in a key market. Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 81. Case study examples Elastic Bandages (2) Approach: Conducted in-depth interviews with clinical physicians, hospital pharmacists, and hospital administrators in France. Methods: Primary research and analysis Results : Established a build-up of various costs across interviewees and aggregated into total usage cost. Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts
  • 82. CONTACT US … Jean-François MAZELIER General Manager Should you have any questions or should you need any additional information, please feel free to contact us: medipharmanetwork@hotmail.fr Cell : +336 980 690 75 Medipharm@Network 2, Esplanade de la Gare 95.110 - Sannois - FRANCE - Siret : 493 614 812 000 29 - VAT: FR 59 493 614 812 Ask Medipharm@Network to take advice from French Healthcare Payers or Medical Experts